chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report received from a contactable reporter(s) (Other HCP). A 93-year-old male patient received BNT162b2 (BNT162B2), in Feb2020 as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and in 2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 93 years for Covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 09Feb2022, outcome "unknown" and all described as "Covid test result=Positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09Feb2022) Positive, notes: Nasal Swab. Clinical information: The patient did not received any other vaccine in four weeks and no other medications in two weeks. No COVID prior vaccination. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Sender's Comments: Based on the known safety profile of the vaccine  BNT162b2, a causal relation between the reported events Covid19, Drug ineffective and the administration of the vaccine cannot be excluded. Linked Report(s): US-PFIZER INC-202200655282 similar report from same reporter.
The next day after the vaccine she got a weird itch across her shoulders and base of neck. No sign of rash , no sign of shingle. Described the itch as under her skin. Continuous for a month, bad at beginning but has gotten better. Also had a headache the day after but went away the same day.
Stroke, Left side of her body effected/Something was wrong, Movement effected, Coordination abnormal, Blood clot; Woke up shaking; Eyesight effected; This spontaneous case was reported by an other caregiver (subsequently medically confirmed) and describes the occurrence of CEREBROVASCULAR ACCIDENT (Stroke, Left side of her body effected/Something was wrong, Movement effected, Coordination abnormal, Blood clot), TREMOR (Woke up shaking) and VISUAL IMPAIRMENT (Eyesight effected) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seizure.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient experienced CEREBROVASCULAR ACCIDENT (Stroke, Left side of her body effected/Something was wrong, Movement effected, Coordination abnormal, Blood clot) (seriousness criteria hospitalization prolonged, disability and life threatening), TREMOR (Woke up shaking) (seriousness criterion hospitalization prolonged) and VISUAL IMPAIRMENT (Eyesight effected) (seriousness criterion hospitalization prolonged). The patient was hospitalized on sometime in March 2021 due to CEREBROVASCULAR ACCIDENT. The patient was treated with Rehabilitation therapy for Cerebrovascular accident. At the time of the report, CEREBROVASCULAR ACCIDENT (Stroke, Left side of her body effected/Something was wrong, Movement effected, Coordination abnormal, Blood clot), TREMOR (Woke up shaking) and VISUAL IMPAIRMENT (Eyesight effected) outcome was unknown. Unknown      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Products known to have been used by the patient, within two weeks prior to the event, included seizure medication. Treatment for the event included intensive care and stroke unit.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, Very limited information regarding this event has been provided at this time. Further information has been requested.
Swelling, redness, erythema, 3x3 cm with induration, non tender, no systemic reaction. No signs of cellulitis, stable vital signs. Treated symptomatic, follow-up the next day.
Per vaccinator, while attempting to administer vaccination, the needle retracted prematurely and the vaccine sprayed out. Vaccinator estimated about 2/3rd of the dose was received by the patient, however the patient stated she felt that she did not received even 1/2 of the dose. After some discussion, a replacement vaccine dose was administered.   Syringe/needle was Vanishpoint brand
fully vaccinated with covid vaccine x 3. tested postitive for covid on 1/13/22. admitted to hospital on 01/22/2022. Expired on 01/26/2022 while still hospitalized.
Shot 1:  Vaccine was given on March 24, 2021 and I woke up at 2:00/am March 25, 2021 with horrible headache and pain behind right eye.  Seen ophthalmologist on April 2, 2021.  Pain and headache continued and became worse.  Continued regular visits with ophthalmologist.  Pain continued behind right eye so I was sent for CT scan of brain,  which showed normal at that time.  Pain behind right eye continued.   I had my second vaccine on April 21, 2021 and April 25, 2021 woke up feeling very strange.  Throat was getting numb and left side of body was numb.  Layed back down for a few hours and then went to work.  By 6:15/pm was not feeling well at all and went home and went to bed.  April 26, 2021 8:00/am was headed to Ophthalmologist and started having very blurry vision and numbness again and went straight to ER instead..  Was given MRI and CT scans and diagnosed with a Arterial Stroke of the Occipital lobe.    Was admitted to Hospital  Pain behind right eye went away after stroke but now have no vision midline to the left out of either eye.  Currently being treated by the specialist of for vision issues
Aches & chills full day after vaccine. 3 days after arm hurts where vaccine occurred.
Fever of 105 F, seizure & vomiting. 5th DTP, no prior problems. No family hx of seizure or allergies. Child is well now
arm swelling; generalized itching. Pt prefers to see outside PCP. She was advised to see PCP.
Severe diarrhea lasting from 4/9/2021 thru 6/24/2021. CAT scan and colonoscopy did not reveal cause. Treatment with Lomotil and colestipol did not resolve symptoms. Diarrhea just stopped without any reason. Moderna booster shot on 11/4/2021. Diarrhea within a few days.  Back on Lomotil and colestipol but no help so far as of this date: 11/2/2021.
I have had tinnitus in both ears for about a week and a half now without it going away. I've never had this before and there does not seem to be a reason for it.
Blood clot caused collapse and when he was found he was sent to the Hospital where he died as a result
Patient received the power portion / reconstituted with sterile water; Patient received the power portion / reconstituted with sterile water; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 11-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA392A, expiry date 12th January 2027) for prophylaxis.   Previously administered products included Menveo (1st dose received on an unknown date).   On 1st June 2021, the patient received the 2nd dose of Menveo. On 1st June 2021, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The reporter was medical assistance. The reporter stated that the patient received the power portion of Menveo reconstituted with sterile water which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The health care professional did not had lyophilize portions lot number/expiry date. The reported batch number AMXA3928 was not available in sales data sheet, hence updated to AMVA392A. The reporter did not consent to follow-up.
I HAVE DEVELOPED BELL'S PALSY INVOLVING THE LEFT SIDE OF MY FACE
severe swelling of Right parotid gland; developed lymphadenopathy; . This case was reported by a physician and described the occurrence of parotid swelling in a 59-year-old patient who received Herpes zoster (Shingrix) (batch number 3HT5J, expiry date 26th January 2022) for prophylaxis.   On 11th January 2021, the patient received the 1st dose of Shingrix. In January 2021, less than a week after receiving Shingrix, the patient experienced parotid swelling and lymphadenopathy. On an unknown date, the outcome of the parotid swelling and lymphadenopathy were unknown.   It was unknown if the reporter considered the parotid swelling and lymphadenopathy to be related to Shingrix.  Additional details were provided as follows:  The age at vaccination was not reported. After receiving first dose of Shingrix, the patient experienced swelling of right parotid gland and 1 or 2 days after, on left arm developed lymphadenopathy. The reported batch number 38T5J for 2nd dose of Shingrix did not exist and was updated to 3HT5J per the sales database. The reporter did not consent to follow up.
Patient's mom reported fever 102 degrees F (oral) x 24 hrs after receiving vaccine w/rash at injection site 48 hrs. after injection. Both subsided.
Roughly 30 minutes after receiving the shot, I developed a small rash on my forearm, on the same arm that I got the shot in.  It was not itchy and only slightly raised in a couple spots.
Within two weeks of getting my second dosage of the Pfizer Covid vaccine, I developed panuveitis; My ophthalmologist diagnosed me with TINU, Tubulointerstitial Nephritis and Uveitis Syndrome; I experienced pain, sensitivity to light, and ankle sores; I experienced pain, sensitivity to light, and ankle sores; This is a spontaneous report from a contactable physician (patient). A 25-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9264), via an unspecified route of administration in arm left on 20Jan2021 (at the age of 25-year-old) as a dose 2, single for COVID-19 immunisation. The patient's medical history was reported as none, No family history of autoimmune disease or significant medical history of disease. The patient had no known allergies. The patient's concomitant medications received within 2 weeks of vaccination was reported as no. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL1283), via an unspecified route of administration in left arm on 20Jan2021 at 05:00 PM (at the age of 25-year-old) as a dose 1, single for COVID-19 immunisation. It was reported that, the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19 was reported as no. On an unspecified date in 2021, within two weeks of getting his second dosage of the Pfizer Covid vaccine, the patient developed panuveitis. Stated that, his ophthalmologist diagnosed him with TINU, Tubulointerstitial Nephritis and Uveitis Syndrome. On an unspecified date in 2021, the patient experienced pain, sensitivity to light and ankle sores and had to go to urgent care clinic to get steroid eye drops to reduce inflammation in his eye. The adverse events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The reporter seriousness and seriousness criteria was non serious. Treatment medication included prednisone eye drops. Device date was on 01Jul2021. The outcome of the events was not recovered.; Sender's Comments: Based on the temporal relation between the BNT162b2 and the onset of Tubulointerstitial Nephritis and Uveitis, the association cannot be ruled out. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Patient received her Second Covid 19 vaccine and then woke up with muscle pain, hip pain, chills, and cough.  she had a temp of 102.8.  Her symptoms resolved within 24 hours.  She received the BioNTech Pfizer vaccine
This spontaneous report was received from a female patient of unknown age reporting on herself. The concurrent conditions and medical history were not provided. On 08-DEC-2015 the patient was vaccinated with ZOSTAVAX (route, dose and indication were not provided). Concomitant therapies were not provided. On 09-DEC-2015, the patient experienced pain around the vaccine area and redness. The outcome of vaccination site pain and erythema was unknown. Additional information is not expected because the caller refused to provide any information.
Student received vaccine as part of employee vaccination clinic. Complained of swollen tongue and throat to preceptor who told her to go to urgent care. Per pt report she received a steroid injection and PO BENADRYL and symptoms resolved.
mom states whenever child had vax she had a relapse of transverse myelitis (C6-T6); mom being followed by MD, 8/30 devel pain,weakness, 9/9 T6 paralysis.
Strong headache; Mild facial swelling; Bent down and felt pressure on head/Lot of pressure in the head; Bent down and felt the pressure on face; Rash; Mild nauseated; Pain on the vaccinated arm; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Mild facial swelling), HEAD DISCOMFORT (Bent down and felt pressure on head/Lot of pressure in the head), DISCOMFORT (Bent down and felt the pressure on face), RASH (Rash) and HEADACHE (Strong headache) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included SPIRONOLACTONE for Acne, CYCLOBENZAPRINE for Muscle relaxant.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Pain on the vaccinated arm). On 28-Apr-2021, the patient experienced NAUSEA (Mild nauseated). On 29-Apr-2021, the patient experienced RASH (Rash). On 01-May-2021, the patient experienced SWELLING FACE (Mild facial swelling), HEAD DISCOMFORT (Bent down and felt pressure on head/Lot of pressure in the head) and DISCOMFORT (Bent down and felt the pressure on face). On 04-May-2021, the patient experienced HEADACHE (Strong headache). The patient was treated with IBUPROFEN on 01-May-2021 at a dose of 200 mg,1 tablet in the afternoon, and 2 tablets in the evening and PARACETAMOL (TYLENOL) on 06-May-2021 at a dose of 500 mg,1/2 tablet. On 30-Apr-2021, VACCINATION SITE PAIN (Pain on the vaccinated arm) had resolved. On 02-May-2021, SWELLING FACE (Mild facial swelling) had resolved. On 05-May-2021, NAUSEA (Mild nauseated) had resolved. At the time of the report, HEAD DISCOMFORT (Bent down and felt pressure on head/Lot of pressure in the head), DISCOMFORT (Bent down and felt the pressure on face), RASH (Rash) and HEADACHE (Strong headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, Computerised tomogram: normal (normal) the result did not show any bleeding or blood clot.. On 05-May-2021, Magnetic resonance imaging: normal (normal) MRI of the head-the result did not show any bleeding or blood clot.. On an unknown date, Fibrin D dimer: 1.43 (High) elevated D-dimer=1.43 (above normal standard level <0.49).         Treatment drugs include Ibuprofen 200mg 1 tablet in the afternoon, and 2 tablets in the evening on 01-May-2021. Acetaminophen 500mg 1/2 tablet on 06-May-2021  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-110367 (Patient Link).
Patient developed dyspnea - perceived shortness of breath, burning with inspiration. Feeling like her lips were swollen.  Dizziness and feeling weakness per legs.  No h/o panic attacks. Would try to calm down her difficulty with breathing but her distress would recur.  She had inability to lie down due to resp. distress
On 12/09/2021. Patient received adult dose (age 12+) at this location 12:30pm. Contacted father at 3:00pm and he reported no adverse events. Consulted father on difference between each vaccine and general side effects to expect. Father will continue to monitor his daughter and will follow up with pharmacy if necessary.  Intern given incorrect vaccine due to insufficient education on age range and proper training has been issued to avoid future incidents.
Abdominal pain, nausea, chills. Chills lasted until 10 PM. Abdominal pain increased to very significant on January 29 and 30. Went to ER early Jan 31. Abdominal pain only ended on Feb 2.
Information has been received from a legal firm concerning an approximately one year old male pt who was first exposed to vaccinations containing the mercury-based preservative thimerosal in or about October 1994 and thereafter up through and including the year 1999. It is alleged that as a result of the pt's exposure to thimerosal, he sustained severe and permanent personal injuries including being diagnosed with severe autism, neurological disorders as well as other severe and permanent health consequences. It is also alleged that the pt sustained further neurological insult including exacerbation of the pt's alleged thimerosal induced neurological disorders from other vaccines including the MMR II which he receive din the time from between October 1994 and 1999. The pt's severe and permanent personal injuries, severe autism, neurological disorders, severe and permanent health consequences and mercury poisoning have persisted. Upon internal review, the pt's severe and permanent personal injuries, severe autism, neurological disorders, severe and permanent health consequences and mercury poisoning were considered to be other important medical events. No further info is available.
The injection site developed into a 7-cm diameter bump with firm texture.  It was sore.  The next day, the bump improves and become smaller.  However, it is red and still sore with touch.  However, it does not impact my arm movements or daily activities.
Fever to 102 degrees for 2 nights, headache; 5 inch rash on injection site lasting 6 days ( and counting), rash is warm to the touch.
Rash and swelling on neck at collar line. Swelling approx 1 inch high at peak and three inches long and wide Itches , some pain in shin on touching  vaccination arm, left side
Patient received his booster dose at the pharmacy. Following administration he was instructed to wait the 15 minutes post vaccine to monitor for side effects. Within a couple minutes he felt faint and passed out. He was sitting on a chair and went to put his head between his legs and just kept going forward and fell on the ground. He hit his head on an end cap display in the store and started bleeding. EMTs were called to the scene and patient was transported to local hospital for additional care.
I just had a headache. I stayed in bed for 1 day after the vaccine because I still had a headache. I just took some Advil.   I did test positive for COVID on November 3rd. I had coughing, sneezing, and headache. I had a virtual visit with my doctor and she called in some medicine(prednisone and Zithromax)  and she had me to do the antibody infusion.
shortness of breath, wheeze at approx 5 pm, pt took benadryl 50 on his own as well as albuterol inhaler
Flushing-redness on hands, legs, shoulder and buttocks comes and goes. Called her Dr. ; said to go on Claritin for  2 wks. I had suggested Benadryl, prior to talking to her Doctor.
Dizziness, Headache, Fever, NauseaVomiting, chills, diaphoresis Narrative:
Had chills and high fever ranging from 99 to 102 throughout the duration which was about 4 hours. Also, aches and pains I already had were worse and parts of me that were not achy in the first place were achy. Woke up the next morning with a raging headache and some aches and pains, but felt a lot better. I've felt better little by little as the week has passed, but still more fatigued than usual.
chills; diarrhea; tired/fatigue/couldn't even lift her head off the pillow; vomiting; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the parent.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 57 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "chills"; DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; FATIGUE (non-serious), outcome "unknown", described as "tired/fatigue/couldn't even lift her head off the pillow"; VOMITING (non-serious), outcome "unknown", described as "vomiting".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Incorrect vaccine administered to 4 month old infant.  Within 12 hours of administration developed 101.9 rectal temp, gray/white stool.   Parents administered oral acetaminophen and infant vomited.  He developed loose stool that continued until 12/13.  PCR for enteric pathogens on 12/13 was negative.  12/14 had pasty/formed BM.  12/2 father reported infant had been sleeping more than normal since administration of HPV vaccination.  See in the office 12/13 for 5 days of cough, nasal congestion.  No fever, wheezing.  Normal exam.  Rapid influenza A/B and SARS-Covid antigen negative.  RSV antigen negative.  Diagnosed with viral URI and symptomatic care advised.
PATIENT COMPLAINED OF DIFFUSE ITCHING, WHICH SARTED 2 DAYS AFTER RECIVING THE VACCINE THAT LASTED FOR A COUPLE OF DAYS
Myalgias, headache, malaise, erythema at and lateral to injection site.